Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 7/20 | 0.62 |
| ▸ | ROS1 | P08922 | 6/20 | 0.62 |
| ▸ | EGFR | P00533 | 12/20 | 0.62 |
| ▸ | ZAP70 | P43403 | 1/20 | 0.52 |
| ▸ | INSR | P06213 | 1/20 | 0.52 |
| ▸ | IGF1R | P08069 | 1/20 | 0.52 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26906635 | 1.00 | ALK (0.62) | ALKROS1EGFRZAP70INSR | |
| SCHEMBL27119073 | 0.88 | ROS1 (0.70) | ALKROS1EGFRLRRK2 | |
| SCHEMBL29904633 | 0.88 | ROS1 (0.70) | ALKROS1EGFRLRRK2 | |
| SCHEMBL26906566 | 0.85 | ROS1 (0.68) | ALKROS1EGFRLRRK2 | |
| SCHEMBL29904648 | 0.85 | ROS1 (0.68) | ALKROS1EGFRLRRK2 | |
| SCHEMBL29904632 | 0.85 | ALK (0.71) | ALKROS1EGFRINSRIGF1R | |
| SCHEMBL26906765 | 0.85 | ALK (0.71) | ALKROS1EGFRINSRIGF1R | |
| SCHEMBL27115493 | 0.84 | ALK (0.75) | ALKROS1EGFRLRRK2 | |
| SCHEMBL29904621 | 0.83 | ALK (0.68) | ALKROS1EGFR | |
| SCHEMBL26906503 | 0.83 | ALK (0.68) | ALKROS1EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022211573-A1 | PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사 테라펙스 | 2022-10-06 | — | — | WO | claimed |
| WO-2022211573-A1 | PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사 테라펙스 | 2022-10-06 | — | — | WO | disclosed |